Search clinical trials for: Dabigatran etexilate

Total 297 results

Kaohsiung Medical University

Recruiting

Precision Medicine Platform for Novel Oral Anticoagulants

Anticoagulant Adverse Reaction

Taiwan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years

Hypertension

United States, Russian Federation, India
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Brian O'Neill MD
Lifetech Scientific (Shenzhen) Co., Ltd.

Not yet recruiting

Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF (CORRAL-AF)

Atrial Fibrillation | Left Atrial Appendage Thrombosis | CVA

United States
Craig L Slingluff, Jr
Theraclion

Active, not recruiting

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors (AM-003)

Melanoma | Cervical Cancer | Breast Cancer | Hepatocellular Carcinoma | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Small-cell Lung Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability High | Squamous Cell Cancer

United States
Daniel Zimpfer, MD

Terminated

Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)

Thrombosis | Bleeding

Austria
Boehringer Ingelheim

Completed

Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin

Healthy
Georg Nickenig
Boehringer Ingelheim

Completed

Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation (ODIn-AF)

Atrial Fibrillation | Oral Anticoagulation | Cardioembolic Events

Germany
University of Rhode Island
Boehringer Ingelheim; Alzheimer's Drug Discovery Foundation

Unknown

A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.

Mild Cognitive Impairment | Mild Alzheimer's Disease
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM); Patient-Centered Outcomes Research Institute

Enrolling by invitation

The DARE Warfarin CER Study

Pulmonary Embolism | Deep Venous Thrombosis

United States
Medical University of Vienna

Completed

Antithrombotic Triple Therapy in Humans

Atrial Fibrillation | Acute Coronary Syndrome

Austria
Boehringer Ingelheim

Completed

Secondary Prevention of Venous Thrombo Embolism (VTE). (RE-MEDY)

Thromboembolism

United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian... and more
Deutsches Herzzentrum Muenchen

Terminated

Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-2)

Atherosclerosis | Atrial Fibrillation | Coronary Heart Disease | Acute Coronary Syndrome

Germany
Pfizer

Completed

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

Healthy

Belgium
Lagos State Health Service Commission

Unknown

Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering

Post Anaesthetic Shivering
Assistance Publique - Hôpitaux de Paris

Completed

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over (PRESAGE-ACO)

Atrial Fibrillation

France
Yokohama City University Medical Center
Yokohama City University

Unknown

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran (RIVAL-AF)

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers

Healthy
University of Texas at Austin
University of Kansas

Not yet recruiting

Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage

Anticoagulants; Increased
Bristol-Myers Squibb

Completed

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

Atrial Fibrillation
Boehringer Ingelheim

Completed

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism

Austria, Belgium, Czech Republic, Denmark, Finland, France, Hungary, Italy, Netherlands, Norway, South Africa, Sweden
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

Coronary Disease

Brazil
Boehringer Ingelheim

Completed

Bioavailability of BIBR 953 ZW Under Influence of Food in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects.

Healthy
IHF GmbH - Institut für Herzinfarktforschung
OrbusNeich

Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (COSTA)

Coronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMI

Germany
Stéphane Zuily
International Society on Thrombosis and Haemostasis

Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants (OBSTINATE)

Thrombosis | Antiphospholipid Syndrome | Anticoagulants Causing Adverse Effects in Therapeutic Use

France
Fondazione per la Ricerca Ospedale Maggiore

Completed

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms (MPN-DOACs)

Myeloproliferative Neoplasm

Italy, United Kingdom, Germany, France, United States, Spain, Canada
Boehringer Ingelheim

Completed

Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food

Healthy
Ottawa Heart Institute Research Corporation
Bristol-Myers Squibb; Bayer; Boehringer Ingelheim; Heart and Stroke Foundation...

Completed

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events (BRUISECONTROL2)

Hematoma

Canada, Israel
Bayer
Janssen Scientific Affairs, LLC

Completed

Use of Direct Oral Anticoagulants in UK

Stroke

United Kingdom
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

Stroke | Atrial Fibrillation | Frailty | Anticoagulant-induced Bleeding

United States
Bristol-Myers Squibb

Completed

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Atrial Fibrillation
Mayo Clinic

Terminated

Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

Acute DVT of Lower Extremity

United States
Pfizer

Completed

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

Atrial Fibrillation

Korea, Republic of
Boehringer Ingelheim

Completed

Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

BIBR 953 ZW in Healthy Elderly Subjects

Healthy
Bayer
Janssen, LP

Completed

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) (REATTAIN)

Atrial Fibrillation

Sweden
Population Health Research Institute
Hamilton Health Sciences Corporation

Recruiting

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial (DANCE)

Bleeding Post Cardiac Surgery | Indication for Anticoagulation

Canada
Fundación de Investigación Biomédica - Hospital...

Active, not recruiting

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

Atrial Fibrillation

Spain
Boehringer Ingelheim

Completed

Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers

Healthy
University of Florida

Completed

Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy

Coronary Artery Disease

United States
Martini Hospital Groningen

Completed

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery (DARINA)

Venous Thromboembolism

Netherlands
University of Malta
Università degli Studi dell'Insubria

Recruiting

DOAC in Unusual Site Venous Thrombosis (DUST)

Cerebral Vein Thrombosis | Renal Vein Thrombosis | Retinal Vein Thrombosis | Splanchnic Vein Thrombosis | Ovarian Vein Thrombosis

Thailand, Spain, United States, Italy, Slovenia, France, Israel, Canada, Malta, Netherlands
Malmö University
Odontologisk Forskning i Region Skåne (OFRS)

Completed

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

Postoperative Complications | Hemorrhage | Anticoagulant-induced Bleeding | Oral Surgical Procedures | Anticoagulants Causing Adverse Effects in Therapeutic Use | Surgery, Oral

Sweden
University of Pavia

Completed

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON) (ORGANON)

Diabetes

Italy
Boehringer Ingelheim

Completed

Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin

Healthy
University of Aarhus
Odense University Hospital; Karolinska University Hospital; Oslo University Hospital and other collaborators

Recruiting

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation (Occlusion-AF)

Stroke | Atrial Fibrillation

Sweden, Finland, Norway, Denmark, Germany
Pfizer

Active, not recruiting

Anticoagulation in Patients With Venous Thromboembolism and Cancer (VICTORIE)

Neoplasms | Embolism

United Kingdom
Pfizer

Completed

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

Venous Thromboembolism

Korea, Republic of
Boehringer Ingelheim

Completed

Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males

Healthy

Search clinical trials for: Dabigatran etexilate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations